Previous Close | 29.58 |
1-Year Change | 17.75% |
6-Months Change | -8.9% |
3-Months Change | -18.04% |
Moving Avg (50d) | 36.36 |
Moving Avg (200d) | 35.468 |
ESG Rating | - |
Exchange | NASDAQ |
Market Cap. | 0.953B |
Beta (3-Years) | 0.64 |
Revenue Growth (ttm) | 9.62% |
Net Profit Margin (ttm) | 14.78% |
Return On Assets (ttm) | 5.42% |
EPS (ttm) | 2.32 |
PE Ratio (ttm) | 12.75 |
Dividend Yield | % |
Asset Description: | Collegium Pharmaceutical, Inc. |
Predicted Direction: | Sell |
Signal Strength: | Sell |
Forecast Date: | 2024-11-13 00:00:00 |
Strong Buy | ||
Buy | ||
Neutral | ||
Sell | ||
Strong Sell |
2% | 5% | 7% | 10% | 15% | 20% |
30.6 | 31.5 | 32.1 | 33 | 34.5 | 36 |
Disclaimer - Please note that the use of AI to analyse contents may occasionally generate incorrect information.
Our cutting-edge algorithms employ macroeconomic data, fundamental and technical analysis indicators to accurately predict the optimal position for short-term trading
By harnessing these signals, we power our asset allocation tools, backtesting tool and portfolio management process, ensuring maximum returns for your investments.
Sector: | Health Care |
Industry: | Pharmaceuticals |
Country: | United States |